Recent Finacing
Recent Raise
SynapDx develops a blood-based RNA gene-expression diagnostic that uses sequencing and proprietary analytics to identify children at risk for autism spectrum disorder and supports clinical validation.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors